MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,243,000 | -35.0% | 20,606 | -50.4% | 0.07% | -33.7% |
Q1 2016 | $1,911,000 | +709.7% | 41,562 | +749.9% | 0.10% | +621.4% |
Q4 2015 | $236,000 | +13.5% | 4,890 | 0.0% | 0.01% | +7.7% |
Q3 2015 | $208,000 | -25.4% | 4,890 | +100.0% | 0.01% | -13.3% |
Q2 2015 | $279,000 | -86.6% | 2,445 | -84.9% | 0.02% | -86.5% |
Q1 2015 | $2,089,000 | +785.2% | 16,186 | +578.4% | 0.11% | +753.8% |
Q3 2014 | $236,000 | +4.4% | 2,386 | -32.5% | 0.01% | +8.3% |
Q4 2013 | $226,000 | +6.6% | 3,536 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $212,000 | – | 3,536 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |